Interagency Cooperation.
Section 11
SEC. 11. Interagency Cooperation. - The VIP shall collaborate with the DOH, RITM, FDA, DA, DENR, DFA, CHED, UP-NIH, Department of Finance, and other relevant government agencies, in accessing and mobilizing available information, reports, technical expertise, equipment, materials and supplies as may be required to implement this Act. The RITM shall retain its current functions under the DOH and shall collaborate with the VIP. It shall continue to provide expertise in the detection and identification of emerging infectious diseases and laboratory support. In line with its current mandate and in close collaboration with the VIP, the RITM shall conduct research, surveillance, and diagnosis for newly identified pathogens to formulate effective strategies for the prevention and control of emerging diseases. The scientific findings of the VIP, RITM, and other concerned agencies shall be integrated in the plans relating to disease control and prevention of the Inter-Agency Task Force on Emerging Infectious Diseases, as created by Executive Order No. 168, series of 2014, and the National Task Force to prevent the entry of animal-borne diseases, as created by Executive Order No. 105, series of 2020, or its successor body, for the management of public health emergencies relating to infectious diseases.